Alseres Pharmaceuticals Inc.
Description Alseres Pharmaceuticals, Inc., a development stage biotechnology company, focuses on the development of diagnostic products primarily for disorders in the central nervous system. Its clinical product candidate includes Altropane, which is based on the molecular imaging program focusing on the diagnosis of Parkinsonian syndromes (PS), including Parkinsons disease (PD) and dementia with lewy bodies. The Altropane molecular imaging agent is intended to be used for the differential diagnosis of PS, including PD, and non-PS in patients with an upper extremity tremor. The company has granted a worldwide sublicense to research, develop, and commercialize Altropane to Navidea Biopharmaceuticals, Inc. Alseres Pharmaceuticals, Inc. was formerly known as Boston Life Sciences, Inc. and changed its name to Alseres Pharmaceuticals, Inc. in June 2007. Alseres Pharmaceuticals, Inc. was founded in 1972 and is headquartered in Hopkinton, Massachusetts. To view the detailed information, you need to SUBSCRIBE with us. |
 |